Cargando…
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509066/ https://www.ncbi.nlm.nih.gov/pubmed/35984103 http://dx.doi.org/10.1097/CM9.0000000000002288 |
| _version_ | 1784797153041842176 |
|---|---|
| author | Mei, Heng Chen, Fangping Han, Yue Hou, Ming Huang, He Huang, Xiaojun Li, Yuhua Liang, Aibin Liu, Qifa Niu, Ting Peng, Jun Qian, Wenbin Song, Yongping Wang, Jianxiang Wang, Ying Wu, Depei Xu, Kailin Yang, Linhua Yang, Renchi Zhang, Lei Zhang, Liansheng Zhang, Xi Zhang, Xiaohui Zhao, Weili Han, Weidong Hu, Yu |
| author_facet | Mei, Heng Chen, Fangping Han, Yue Hou, Ming Huang, He Huang, Xiaojun Li, Yuhua Liang, Aibin Liu, Qifa Niu, Ting Peng, Jun Qian, Wenbin Song, Yongping Wang, Jianxiang Wang, Ying Wu, Depei Xu, Kailin Yang, Linhua Yang, Renchi Zhang, Lei Zhang, Liansheng Zhang, Xi Zhang, Xiaohui Zhao, Weili Han, Weidong Hu, Yu |
| author_sort | Mei, Heng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9509066 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95090662022-09-26 Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy Mei, Heng Chen, Fangping Han, Yue Hou, Ming Huang, He Huang, Xiaojun Li, Yuhua Liang, Aibin Liu, Qifa Niu, Ting Peng, Jun Qian, Wenbin Song, Yongping Wang, Jianxiang Wang, Ying Wu, Depei Xu, Kailin Yang, Linhua Yang, Renchi Zhang, Lei Zhang, Liansheng Zhang, Xi Zhang, Xiaohui Zhao, Weili Han, Weidong Hu, Yu Chin Med J (Engl) Consensus Statement Lippincott Williams & Wilkins 2022-07-20 2022-08-19 /pmc/articles/PMC9509066/ /pubmed/35984103 http://dx.doi.org/10.1097/CM9.0000000000002288 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Consensus Statement Mei, Heng Chen, Fangping Han, Yue Hou, Ming Huang, He Huang, Xiaojun Li, Yuhua Liang, Aibin Liu, Qifa Niu, Ting Peng, Jun Qian, Wenbin Song, Yongping Wang, Jianxiang Wang, Ying Wu, Depei Xu, Kailin Yang, Linhua Yang, Renchi Zhang, Lei Zhang, Liansheng Zhang, Xi Zhang, Xiaohui Zhao, Weili Han, Weidong Hu, Yu Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy |
| title | Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy |
| title_full | Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy |
| title_fullStr | Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy |
| title_full_unstemmed | Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy |
| title_short | Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy |
| title_sort | chinese expert consensus on the management of chimeric antigen receptor t cell therapy-associated coagulopathy |
| topic | Consensus Statement |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509066/ https://www.ncbi.nlm.nih.gov/pubmed/35984103 http://dx.doi.org/10.1097/CM9.0000000000002288 |
| work_keys_str_mv | AT meiheng chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT chenfangping chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT hanyue chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT houming chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT huanghe chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT huangxiaojun chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT liyuhua chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT liangaibin chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT liuqifa chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT niuting chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT pengjun chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT qianwenbin chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT songyongping chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT wangjianxiang chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT wangying chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT wudepei chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT xukailin chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT yanglinhua chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT yangrenchi chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT zhanglei chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT zhangliansheng chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT zhangxi chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT zhangxiaohui chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT zhaoweili chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT hanweidong chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy AT huyu chineseexpertconsensusonthemanagementofchimericantigenreceptortcelltherapyassociatedcoagulopathy |